Canon Announces New Biomedical Company
Canon announced that it established Canon BioMedical, a wholly owned biomedical business to develop, manufacture, and market operations related to Canon’s life-science and molecular diagnostics platform.
Canon U.S.A announced on March 2, 2015 that it established Canon BioMedical to develop, manufacture, and market operations related to Canon’s life-science and molecular diagnostics platform. The company also plans to expand the use of Canon technology into other medical fields. Long-term growth includes untapped markets for Canon such as life science, healthcare, and medical analysis through the use of existing and future Canon technologies, as well as partnerships.
"We are truly excited and proud to launch Canon BioMedical, Inc., an American-born worldwide headquarters committed to bringing to market innovative technologies and solutions," said Joe Adachi, chairman and CEO, Canon U.S.A., Inc., in a press release. "We look forward to bringing Canon technology to clinicians and scientists all over the world in an effort to assist in improving human health and in advancing science."
Source: Canon
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
